Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy

NCT00225875 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Thrombocytopenic Purpura

Interventions

DRUG: Mabthéra

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]